Archive for 'Tag Archives: 'Wallonia''

All in on cancer immunotherapy

All in on cancer immunotherapy

Founded in 2011, iTeos began its activities at the end of 2012. The company is active in the field of cancer immunotherapy and focuses on the tumor micro-environment to develop innovative drugs. iTeos benefited for its [...]

Biobanking: a vital asset for Belgium scientific excellence

Biobanking: a vital asset for Belgium scientific excellence

In 2014, three French-speaking universities of Belgium (UCL, ULB, ULg, in association with UMons and UNamur) joined forces, with the support of DG06, Innoviris and BioWin, to create the Biothèque Wallonie Bruxelles (BWB), the network of [...]

Walloon Biotech and Medtech companies: should you go for an IPO?

Walloon Biotech and Medtech companies: should you go for an IPO?

Initial Public Offerings tend to become a real alternative for more and more European biotech companies. In Wallonia (Belgium), several SMEs (such as Mithra Pharmaceuticals) are seriously considering this option while companies such as Celyad, Bone [...]

MaSTherCell or the future of CMOs

MaSTherCell or the future of CMOs

In an exclusive interview, Hugues Bultot, Chief Executive Officer of MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics, based in Gosselies (Belgium) shares with us his vision for the future of the CMO.   [...]

BioWin: an effective Cluster for innovation in health

BioWin: an effective Cluster for innovation in health

  Guest blogger: Anne-Laure Languille A study conducted by the firm M5 closely examined results obtained by BioWin, the health cluster of Wallonia. The conclusions state the positive impact of the cluster in four key domains: [...]

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences raises € 4.0 million from the Walloon Region (non-dilutive funding)

Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]

Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment

Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment

An exciting new medtech player in Belgium’s Walloon Region – Rosellini Scientific Benelux SA (RSB) – joins the consortium to develop a novel implant system for treating and monitoring glaucoma. The 4-partner consortium, led by iSTAR [...]

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

In March, GlaxoSmithKline(GSK) and the Texas A&M University System (TAMUS) announced the U.S. Department of Health and Human Services (DHHS) had approved the establishment of a $91 million (€70.3 million) influenza-vaccine manufacturing facility as the pillar [...]

Public-private partnership leads to unique Walloon Cell Therapy Platform

Public-private partnership leads to unique Walloon Cell Therapy Platform

As the foundation for the new Walloon Cell Therapy Platform* begins to set in Gosselies, Belgium an exciting new development for Wallonia gets underway. The platform, unique in this sector, will provide Wallonia with a new [...]

Walloon training center Cefochim inaugurates its new biopharmaceutical wing

Walloon training center Cefochim inaugurates its new biopharmaceutical wing

Celebrating ten years of specialized training, the Walloon Training Center for jobs in the chemical and biopharmaceutical industry (CEFOCHIM) located in Seneffe, Belgium, is maintaining its reputation for specialized training with the exciting inauguration of its [...]